Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Arbutus Biopharma Corp.
DescriptionShort interfering RNAs (siRNAs) targeting the Guinea (Makona) strain of Ebola virus formulated with Tekmira's lipid nanoparticle (LNP) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPhase II
Standard IndicationEbola
Indication DetailsTreat patients infected with the Guinea (Makona) strain of Ebola virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today